Lv31
340 积分 2023-10-07 加入
Protease-sensitive Linkers
6小时前
已完结
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling
4天前
已完结
Severely polarized extracellular acidity around tumour cells
18天前
已完结
The Ph paradigm in cancer
18天前
已完结
Melanotransferrin: Search for a function
28天前
已完结
Therapeutic landscape and future direction of metastatic colorectal cancer
30天前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
1个月前
已关闭
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
1个月前
已完结
The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer
3个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
